Arcus Biosciences Inc.

NYSE: RCUS · Real-Time Price · USD
10.37
0.46 (4.64%)
At close: Aug 15, 2025, 3:59 PM
10.64
2.60%
After-hours: Aug 15, 2025, 07:29 PM EDT

Arcus Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-283M -307M -267M 52.83M
Depreciation & Amortization
10M 8M 6M 3.84M
Stock-Based Compensation
76M 73M 65M 55M
Other Working Capital
-9M -85M 615M -367.88M
Other Non-Cash Items
5M -9M 11M 3.47M
Deferred Income Tax
n/a n/a n/a 4.77M
Change in Working Capital
22M -71M 623M -375.62M
Operating Cash Flow
-170M -306M 438M -256.17M
Capital Expenditures
-6M -24M -12M -26.08M
Cash Acquisitions
n/a n/a n/a -22M
Purchase of Investments
-1.04B -788M -1.24B -718.87M
Sales Maturities Of Investments
965M 1.01B 837M 741.08M
Other Investing Acitivies
n/a n/a 3M 22M
Investing Cash Flow
-84M 194M -413M -3.87M
Debt Repayment
47M n/a n/a 5M
Common Stock Repurchased
n/a n/a n/a -6K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 8M 33M 12.34M
Financial Cash Flow
277M 33M 33M 237.34M
Net Cash Flow
23M -79M 58M -22.7M
Free Cash Flow
-176M -330M 426M -282.25M